You are using an older browser version. Please use a supported version for the best MSN experience.

Prometheus Biosciences CEO on the company's ability to raise capital, get FDA approval

Cramer spoke with Prometheus Biosciences CEO Mark McKenna on Friday.
image beaconimage beaconimage beacon